D E Muller-Wiefel
Overview
Explore the profile of D E Muller-Wiefel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
555
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Kemper M, Amon O, Timmermann K, Altrogge H, Muller-Wiefel D
Dtsch Med Wochenschr
. 1998 Apr;
123(9):239-43.
PMID: 9524533
Background And Objective: The treatment of frequently relapsing steroid-sensitive nephrotic syndrome in children with established immunosuppressive drugs (steroids, cyclophosphamide, cyclosporin A) sometimes presents problems because of the expected incidence of...
22.
Ludwig K, Muller-Wiefel D
Nephrol Dial Transplant
. 1998 Mar;
13(1):23-7.
PMID: 9481709
No abstract available.
23.
Kemper M, Altrogge H, Amon O, Muller-Wiefel D
Klin Padiatr
. 1998 Jan;
209(6):373-6.
PMID: 9445922
Haematuria and proteinuria are important symptoms of primary and secondary nephropathies. We report three african children presenting to our center in whom infection with S. haematobium resulted in haematuria and...
24.
Kemper M, Meyer-Jark T, Muller-Wiefel D
Pediatr Nephrol
. 1998 Jan;
11(6):684-6.
PMID: 9438642
To date there are no data concerning IgG subclasses in children with preterminal chronic renal failure (CRF), although a reduction of total serum IgG, including its major subclasses IgG1 and...
25.
Kemper M, Conrad S, Muller-Wiefel D
Eur J Pediatr
. 1997 Jul;
156(7):509-12.
PMID: 9243228
Unlabelled: Primary hyperoxaluria type 2 (PH2) is a rare disease with only 24 patients reported in the literature so far. It should be considered in any patient presenting with urolithiasis...
26.
Ludwig K, Bitzan M, Zimmermann S, Kloth M, Ruder H, Muller-Wiefel D
J Infect Dis
. 1996 Nov;
174(5):1028-39.
PMID: 8896505
The incidence and time course of the immune response to Vero toxin-producing Escherichia coli (VTEC) other than O157 (O26, O55, O111, O128) were determined in 107 children with enteropathic hemolytic...
27.
Kemper M, Muller-Wiefel D
Pediatr Nephrol
. 1996 Aug;
10(4):442-4.
PMID: 8865239
Although nephrocalcinosis is a classical finding in primary hyperoxaluria type 1 (PH 1) associated with a poor renal survival it is exceptional in patients with PH type 2 (PH 2),...
28.
Kemper M, Harps E, Muller-Wiefel D
Clin Nephrol
. 1996 Jul;
46(1):67-9.
PMID: 8832156
Hyperkalemia is a life threatening emergency and warrants immediate treatment because of its deleterious cardiac consequences. Initial measures in mild cases include restriction and binding of dietary potassium, correction of...
29.
Behnke B, Altrogge H, Delling G, Kruse H, Muller-Wiefel D
Clin Nephrol
. 1996 Jul;
46(1):24-9.
PMID: 8832146
To evaluate the natural history of bone mineral density after successful renal transplantation (TPL) modulated by therapeutic strategies in pediatric patients we have studied peripheral and partially proximal quantitative computed...
30.
Latta A, Muller-Wiefel D, Sturm E, Kemper M, Burdelski M, Broelsch C
Clin Nephrol
. 1996 Jul;
46(1):21-3.
PMID: 8832145
Primary hyperoxaluria type 1 (PH 1) is complicated by a high rate of early end-stage renal failure (ESRF). In ESRF combined liver kidney transplantation has emerged as treatment of choice...